The World Health Organization recommends initiating antiretroviral therapy (ART) regardless of CD4 count. We assessed the effect of ART eligibility on treatment uptake and simulated the impact of WHO's recommendations in South Africa.We conducted an empirical analysis of cohort data using a regression discontinuity design, and then used this model for policy simulation. We enrolled all patients (n = 19,279) diagnosed with HIV between August 2011 and December 2013 in the Hlabisa HIV Treatment and Care Programme in rural South Africa. Patients were ART-eligible with CD4<350 cells/mm3 or Stage III/IV illness. We estimated: (1) distribution of first CD4 counts in 2013; (2) probability of initiating ART ≤6 months of HIV diagnosis under existing ...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
Prompt uptake of antiretroviral treatment (ART) is essential to ensure the success of universal test...
Objectives: We investigate the effect of immediate antiretroviral therapy (ART) eligibility on HIV ...
BACKGROUND: The World Health Organization recommends initiating antiretroviral therapy (ART) regardl...
Objectives To assess the relationship between CD4 count at presentation and ART uptake and assess p...
International audienceBackground: While WHO recommendations are to treat people earlier and earlier,...
OBJECTIVE: To evaluate CD4 cell count-driven strategies for the initiation of highly active antiretr...
Objective: To explore the impact of expanded eligibility criteria for antiretroviral therapy (ART) o...
Observational cohort study. Methods Patients presenting to primary care clinics with CD4 cell ...
OBJECTIVE: To report the viral load and CD4 count in HIV-infected, antiretroviral naïve, first -time...
Data from CD4-guided structured treatment interruptions strategies trials performed in industrialise...
Introduction: The World Health Organisation recommends to Treat All people with HIV, ...
Background South Africa implemented universal test and treat (UTT) in September 2016 in an effort t...
Background: South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibili...
International audiencePrompt uptake of antiretroviral treatment (ART) is essential to ensure the suc...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
Prompt uptake of antiretroviral treatment (ART) is essential to ensure the success of universal test...
Objectives: We investigate the effect of immediate antiretroviral therapy (ART) eligibility on HIV ...
BACKGROUND: The World Health Organization recommends initiating antiretroviral therapy (ART) regardl...
Objectives To assess the relationship between CD4 count at presentation and ART uptake and assess p...
International audienceBackground: While WHO recommendations are to treat people earlier and earlier,...
OBJECTIVE: To evaluate CD4 cell count-driven strategies for the initiation of highly active antiretr...
Objective: To explore the impact of expanded eligibility criteria for antiretroviral therapy (ART) o...
Observational cohort study. Methods Patients presenting to primary care clinics with CD4 cell ...
OBJECTIVE: To report the viral load and CD4 count in HIV-infected, antiretroviral naïve, first -time...
Data from CD4-guided structured treatment interruptions strategies trials performed in industrialise...
Introduction: The World Health Organisation recommends to Treat All people with HIV, ...
Background South Africa implemented universal test and treat (UTT) in September 2016 in an effort t...
Background: South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibili...
International audiencePrompt uptake of antiretroviral treatment (ART) is essential to ensure the suc...
Background Antiretroviral therapy (ART) initiation is now recommended irrespective of CD4 count. How...
Prompt uptake of antiretroviral treatment (ART) is essential to ensure the success of universal test...
Objectives: We investigate the effect of immediate antiretroviral therapy (ART) eligibility on HIV ...